The WIB-Philadelphia Chapter honored three women who have helped set the stage and pave the way for the foundation and tremendous growth of the local Life Science industry in the Philadelphia Metro area. The speakers shared their stories, insights on trends in Philly’s Life Science community, challenges as an entrepreneur, and lessons learned. With cocktails and light bites, the event was held on Thursday March 21st 2019 at 5:30pm in the Navy Yard, at Adaptimmune's headquarters. The event was well attended and received with over 90 people registered.
Moderator Kimberly Freeman is Vice President at Adapatimmune US, where she works in Commercial Strategy & Planning. Freeman has extensive oncology experience including R&D, New Product Planning, Marketing, Sales, and National Accounts. Her specialties are Oncology and National Accounts.
Speaker Jane Hollingsworth founded and manages Militia Hill Ventures, an organization that creates and develops high growth, high value life sciences companies, and has successfully founded, financed, grown, managed, and taken public two biopharmaceutical companies. She has been a key senior management member of a fast growing, publicly-traded, multinational Clinical Research Organization (CRO). Hollingsworth co-founded and was CEO of NuPathe, a biopharmaceutical company focused on innovative solutions for diseases of the central nervous system, including neurological and psychiatric disorders. NuPathe was sold to Teva Pharmaceuticals in 2014. She was also Co-founder & EVP of Auxilium Pharmaceuticals, a biopharmaceutical company dedicated to providing innovative solutions for unique diseases that improve health and quality of life, which was sold to Endo Pharmaceuticals in 2015.
Speaker Maria Maccecchini is one of Philadelphia Business Journal’s 2019 Power Women: 12 who are Having an Impact on Bioscience. She founded QR Pharma in May 2008 to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She was also partner and director of two angel groups: Robin Hood Ventures and MidAtlantic Angel Group; Founder and CEO of Symphony Pharmaceuticals/Annovis (a biotech company that sold in 2001 to Transgenomic); General Manager of Bachem Bioscience, the US subsidiary of Bachem AG, Switzerland and Head Molecular Biology Mallinckrodt. Dr. Maccecchini did one postdoc at Caltech and one at the Roche Institute of Immunology. Her PhD in biochemistry is from the Biocenter of Basel with a 2 year visiting fellowship at The Rockefeller University.
Speaker Priya Buhtani is Founder & CEO RegDesk, a venture backed by IBC, Penn Medicine and DreamIt Ventures. RegDeskTM is the developer of a cutting-edge regulatory approval software solution. Its platform delivers regulatory intelligence to medical device and pharmaceutical companies that are ready to penetrate foreign markets. Its mission is to help life sciences companies reduce their time to market, eliminate the risks associated with penetrating new markets, maximize their product revenues and market share, and increase patient access to lifesaving medical devices and therapeutics.